An interchangeable biosimilar additionally demonstrates that it can be substituted for the reference product without increased risk to the patient, even for patients who may be switched back and forth between the reference product and the biosimilar
If symptoms last more than a few weeks or become severe, it is advised to see a doctor
Clinicians should recognize that while GLP-1 receptor agonists effectively reduce visceral fat, they represent one component of comprehensive metabolic disease management
Women under high oxidative stress from chronic inflammation, environmental toxin exposure, high CYP1B1-driven reactive metabolism, or nutritional deficiency face lower GSH availability precisely when glutathione conjugation demand is highest
As MASLD progresses, hepatic inflammation, particularly involving M1 macrophages (Kupffer cells), becomes a key factor in disease progression (63)